You are here: Business & Industry Production & Manufacturing

Production & Manufacturing

Baxter in Manesar,Waluj and Alathur

E-mail Print PDF

Baxter in Manesar:

Baxter’s facility in Manesar, Gurgaon demonstrates excellence in manufacturing for the company’s Medication Delivery and Renal businesses, producing IV and PD solutions.

Boehringer Ingelheim BioXcellence™ offers reliable world-class biopharmaceuticals contract manufacturing to the pharmaceutical and biotechnology industry.

E-mail Print PDF

We offer a complete range of services, from cell line and strain development through process development and large-scale manufacturing to fill and finish. Our extensive portfolio of capabilities and technologies includes the production of antibodies, recombinant proteins, non-antibody scaffolds, Fab fragments as well as pDNA from either mammalian cell culture or microbial fermentation systems.

Galena Biopharma Acquires Mills Pharmaceuticals

E-mail Print PDF

Galena Biopharma, a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, announced it has acquired Mills Pharmaceuticals, which has the worldwide rights to GALE-401 (Anagrelide CR), a patented, controlled release formulation of anagrelide.

Bayer HealthCare launches oncology treatment Xofigo in UK

E-mail Print PDF

Bayer HealthCare has launched Xofigo (radium - 223 dichloride) solution for injection in the UK to treat adults with castration-resistant prostate cancer, symptomatic bone metastases and no known visceral metastases.

PharmaCell signs deal to produce Dendreon' Provenge in Europe

E-mail Print PDF

Netherlands-based PharmaCell has entered into an agreement with Dendreon to be the contract manufacturing organization (CMO) for the European commercial production of its recently approved cellular immunotherapy product Provenge dispersion for infusion.

Aspen proposes to acquire GSK's thrombosis brands and NDB site

E-mail Print PDF

Research-based pharmaceutical and healthcare company GlaxoSmithKline (GSK) has received a proposal from Aspen Global and Aspen Pharmacare Holdings for its thrombosis brands and Notre-Dame de Bondeville (NDB) site.

Medicago wins European patent for influenza virus-like particles in plants

E-mail Print PDF

The European Patent Office (EPO) has granted Medicago a patent protecting exclusive rights to produce influenza virus-like particles (VLPs) in plants through July 2028.

Bionomics commences BNC10 manufacturing activities

E-mail Print PDF

Australia-based international biotechnology company Bionomics has commenced manufacturing activities for anti-cancer stem cell candidate BNC10.

DSM, DecImmune collaborate to develop N2 pathway blocking antibody

E-mail Print PDF

DSM Pharmaceutical Products has entered into collaboration with venture capital funded DecImmune Therapeutics of Cambridge, US.

Sunshine looking for CMOs for breast cancer drug Adva-27a manufacturing

E-mail Print PDF

Sunshine Biopharma has started discussions with contract manufacturing organizations (CMOs) for the production of its multidrug-resistant breast cancer drug, Adva-27a.

Page 1 of 5

  • «
  •  Start 
  •  Prev 
  •  1 
  •  2 
  •  3 
  •  4 
  •  5 
  •  Next 
  •  End 
  • »